Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 144,761 | 144,717 | 189,304 | 226,609 | 82,248 |
| Receivables | 80,142 | 67,824 | 60,360 | 54,612 | 48,494 |
| Inventories | 94,491 | 80,102 | 84,469 | 73,095 | 65,623 |
| Other current assets | 4,155 | 14,413 | 10,626 | 11,290 | 4,507 |
| TOTAL | $337,998 | $307,555 | $345,108 | $365,606 | $201,065 |
| Non-Current Assets | |||||
| PPE Net | 254 | 281 | 307 | 268 | N/A |
| Intangibles | 56 | 56 | 56 | 56 | 56 |
| Other Non-Current Assets | 5,513 | 6,222 | 6,848 | 7,130 | 4,675 |
| TOTAL | $5,823 | $6,559 | $7,211 | $7,454 | $4,731 |
| Total Assets | $343,821 | $314,114 | $352,319 | $373,060 | $205,796 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 51,650 | 34,864 | 47,669 | 28,433 | 31,718 |
| Accrued Expenses | 61,570 | 55,549 | 48,270 | 37,564 | 37,725 |
| Other current liabilities | 47,586 | 38,394 | 32,754 | 43,486 | 34,828 |
| TOTAL | $246,233 | $165,873 | $175,338 | $164,512 | $156,224 |
| Non-Current Liabilities | |||||
| Long Term Debt | 140,971 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 8,518 | 15,078 | 20,672 | 29,350 | 25,402 |
| Other Non-Current Liabilities | 345,339 | 518,450 | 521,201 | 502,846 | 504,566 |
| TOTAL | $486,310 | $518,450 | $521,201 | $502,846 | $504,566 |
| Total Liabilities | $732,543 | $684,323 | $696,539 | $667,358 | $660,790 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 197,849 | 197,035 | 196,225 | 189,460 | 185,053 |
| Common Shares | 196 | 195 | 195 | 188 | 118 |
| Retained earnings | -1,601,029 | -1,579,711 | -1,550,187 | -1,488,262 | -1,549,284 |
| Other shareholders' equity | 2 | 2 | 2 | 2 | 2 |
| TOTAL | $-388,722 | $-370,209 | $-344,220 | $-294,298 | $-454,994 |
| Total Liabilities And Equity | $343,821 | $314,114 | $352,319 | $373,060 | $205,796 |